HomeCompareORYZF vs STAG

ORYZF vs STAG: Dividend Comparison 2026

ORYZF yields 59.88% · STAG yields 3.99%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ORYZF wins by $628.3K in total portfolio value
10 years
ORYZF
ORYZF
● Live price
59.88%
Share price
$3.34
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$647.7K
Annual income
$151,154.17
Full ORYZF calculator →
STAG
STAG Industrial Inc.
● Live price
3.99%
Share price
$36.80
Annual div
$1.47
5Y div CAGR
1%
Payout ratio
72%
After 10 yrs · $10,000 · DRIP
Portfolio value
$19.4K
Annual income
$606.20
Full STAG calculator →

Portfolio growth — ORYZF vs STAG

📍 ORYZF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodORYZFSTAG
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ORYZF + STAG cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ORYZF pays
STAG pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ORYZF
Annual income on $10K today (after 15% tax)
$5,089.82/yr
After 10yr DRIP, annual income (after tax)
$128,481.04/yr
STAG
Annual income on $10K today (after 15% tax)
$339.54/yr
After 10yr DRIP, annual income (after tax)
$515.27/yr
At 15% tax rate, ORYZF beats the other by $127,965.77/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ORYZF + STAG for your $10,000?

ORYZF: 50%STAG: 50%
100% STAG50/50100% ORYZF
Portfolio after 10yr
$333.6K
Annual income
$75,880.19/yr
Blended yield
22.75%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on STAG right now

ORYZF
No analyst data
Altman Z
4.4
Piotroski
2/9
STAG
Analyst Ratings
9
Buy
9
Hold
3
Sell
Consensus: Buy
Price Target
$45.00
+22.3% upside vs current
Range: $39.00 — $59.00
Altman Z
1.2
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ORYZF buys
0
STAG buys
0
No recent congressional trades found for ORYZF or STAG in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricORYZFSTAG
Forward yield59.88%3.99%
Annual dividend / share$2.00$1.47
Payout ratio50%72%
1-year div growth0%0.5%
5-year div CAGR0%1%
Portfolio after 10y$647.7K$19.4K
Annual income after 10y$151,154.17$606.20
Total dividends collected$536.9K$5.0K
Payment frequencyquarterlymonthly
SectorStockREIT

Year-by-year: ORYZF vs STAG ($10,000, DRIP)

YearORYZF PortfolioORYZF Income/yrSTAG PortfolioSTAG Income/yrGap
1← crossover$16,688$5,988.02$10,723$403.45+$6.0KORYZF
2$27,195$9,339.09$11,490$423.42+$15.7KORYZF
3$43,323$14,223.60$12,302$444.01+$31.0KORYZF
4$67,531$21,176.11$13,161$465.24+$54.4KORYZF
5$103,108$30,849.85$14,069$487.12+$89.0KORYZF
6$154,347$44,020.82$15,029$509.63+$139.3KORYZF
7$226,736$61,585.45$16,042$532.80+$210.7KORYZF
8$327,159$84,550.92$17,112$556.61+$310.0KORYZF
9$464,078$114,017.62$18,241$581.08+$445.8KORYZF
10$647,717$151,154.17$19,431$606.20+$628.3KORYZF

ORYZF vs STAG: Complete Analysis 2026

ORYZFStock

Oryzon Genomics S.A., a clinical phase biopharmaceutical company, engages in the discovery and development of epigenetics-based therapeutics for patients with cancer and CNS disorders. Its clinical phase compounds include iadademstat (ORY-1001), a selective LSD1 inhibitor that is in Phase II trials for oncology; and vafidemstat (ORY-2001), a CNS-optimized LSD1 inhibitor, which is in Phase II trials for the treatment of CNS and psychiatric diseases. Its product candidates also comprise ORY-3001, an LSD1 inhibitor that is in preclinical development for the treatment of non-oncological diseases. The company was founded in 2000 and is based in Cornellà de Llobregat, Spain.

Full ORYZF Calculator →

STAGREIT

STAG Industrial is a single-tenant industrial REIT paying monthly dividends. Its portfolio of 500+ warehouses and distribution centers benefits from e-commerce growth. Amazon is its largest tenant. Monthly income frequency makes it attractive for investors who prefer regular cash flow over quarterly payments.

Full STAG Calculator →
📬

Get this ORYZF vs STAG comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ORYZF vs SCHDORYZF vs JEPIORYZF vs OORYZF vs KOORYZF vs MAINORYZF vs PLDORYZF vs EQRORYZF vs VICI

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.